Prime Medicine, Inc.

CRL AI-extracted

PM359

Chronic Granulomatous Disease (CGD)

Date

TBD

FDA decision · Date TBD estimated

What's at stake An FDA complete response letter on PM359 for Chronic Granulomatous Disease (CGD) is in focus around Date TBD.

Primary source · SEC 8-K verified 14h ago

“The Company is working towards final alignment with the FDA, and intends to submit a Biologics License Application (BLA).”